hese grants are earmarked for endeavors in the realm of Tuberculosis (TB) and Human Papillomavirus (HPV) tests on the innovative Co-DX PCR Home platform. The intention behind these grants is to enable the completion of these vital tests, geared toward vital global markets, where the prevalence of these conditions is pronounced.